Health is wealth. Families ensure that everyone is safe and protected, especially during flu season. The flu virus is highly communicable. When one kid gets sick with the flu, there is a tendency that...
Born on October 8, 1941, Jesse Louis Jackson is an American politician, Baptist clergyman, and political activist. In 1984 and 1988, he ran for the Democratic presidential nomination. The Rev. Jesse Jackson, a civil...
The doctor was one of the first two Omicron-positives in India. The 46-year-old Bangalore doctor who was one of the first instances of Omicron in India had slight bodily aches, chills, and a low fever....
Concerns regarding the Omicron strain of coronavirus prompted the Indian Medical Association (IMA) to urge the government to hasten the immunization of children aged 12 to 18. The Indian Medical Association (IMA) warns that...
The Subject Expert Committee on Covid19 has granted ‘Covaxin’ of Bharat Biotech an emergency permit for children 2-18 years old. Bharat Biotech of Hyderabad has completed the trials of phase 2 and phase 3...
US pharmaceutical giant Johnson & Johnson’s single-dose COVID-19 vaccine has received emergency use approval in India, Union Health Minister Mansukh Mandaviya tweeted. “India expands its vaccine basket! Johnson and Johnson’s single-dose COVID-19 vaccine is...
As per the scientists, the Covid-19 vaccine candidate which can be administered through the nose has shown a reduction in both the impact of the disease and transmission of the virus in pre-clinical animal...
“CBSE will conduct classes 10, 12 board exams from May 4 to June 10. The Board will announce the results of classes 10, 12 board exams by July 15,” Education Minister Ramesh Pokhriyal said....
Vaccine candidate(developer/sponsor) Technology Phase of trial(participants) Adverse effects Immune response Location Duration AZD1222(University of Oxford, AstraZeneca) adenovirus vector Phase II–III randomized, interventional (10,260) pending Phase I report pending Phase I report United Kingdom May 2020 to August 2021 Ad5-nCoV(CanSino...
Volunteers in Brazil have begun receiving a trial vaccine against COVID-19, in Latin America’s first phase 3 COVID-19 clinical trial. The trial officially began on Saturday 20th June and will enrol 5,000 volunteers across...
